Mediation analysis of independent treatment effect of guselkumab on health-related quality of life in patients with moderate to severe plaque-type psoriasis: Results from 2 phase 3 studies VOYAGE-1&2

被引：0
|
作者：
Armstrong, April W. [1 ]
Liu, Yan [2 ]
Li, Nan [2 ]
Reich, Kristian [3 ]
Foley, Peter [4 ,5 ]
Li, Shu [6 ]
Fakharzadeh, Steven [2 ,6 ]
Papp, Kim A. [7 ,8 ]
Han, Chenglong [2 ]
机构：
[1] Univ Southern Calif, Los Angeles, CA 90007 USA
[2] Janssen Global Serv LLC, Raritan, NJ USA
[3] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany
[4] Univ Melbourne, St Vincents Hosp Melbourne, Melbourne, Vic, Australia
[5] Skin Hlth Inst, Prob Med Res, Carlton, Vic, Australia
[6] Janssen Res & Dev LLC, Raritan, NJ USA
[7] K Papp Clin Res, Waterloo, ON, Canada
[8] Prob Med Res Inc, Waterloo, ON, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27078
引用
收藏
页码：AB128 / AB128
页数：1
相关论文
共 50 条
  • [1] Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies
    Gordon, K. B.
    Blauvelt, A.
    Foley, P.
    Song, M.
    Wasfi, Y.
    Randazzo, B.
    Shen, Y. K.
    You, Y.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 132 - 139
  • [2] Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2
    Reich, K.
    Gordon, K. B.
    Strober, B. E.
    Armstrong, A. W.
    Miller, M.
    Shen, Y. K.
    You, Y.
    Han, C.
    Yang, Y. W.
    Foley, P.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (06) : 1146 - 1159
  • [3] The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials
    Armstrong, April
    Puig, Luis
    Papp, Kim A.
    Strauss, Marcie E.
    Yang, Ya-Wen
    Cheng, Ru-Fong
    Miller, Megan
    Murase, Jenny E.
    Fernandez-Penas, Pablo
    Han, Chenglong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB235 - AB235
  • [4] Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies
    Armstrong, April W.
    Reich, Kristian
    Foley, Peter
    Han, Chenglong
    Song, Michael
    Shen, Yaung-Kaung
    You, Yin
    Papp, Kim A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (01) : 155 - 164
  • [5] Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies
    April W. Armstrong
    Kristian Reich
    Peter Foley
    Chenglong Han
    Michael Song
    Yaung-Kaung Shen
    Yin You
    Kim A. Papp
    American Journal of Clinical Dermatology, 2019, 20 : 155 - 164
  • [6] Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis
    Armstrong, April W.
    Foley, Peter
    Liu, Yan
    Miller, Megan
    Teneralli, Rachel E.
    Bewley, Anthony
    Gordon, Kenneth B.
    Papp, Kim A.
    Han, Chenglong
    DERMATOLOGY AND THERAPY, 2024, 14 (09) : 2577 - 2589
  • [7] Effect of apremilast and etanercept on pruritus and health-related quality of life in patients with moderate to severe plaque psoriasis: Results from the LIBERATE study
    Green, Lawrence
    Thaci, Diamant
    Zhang, Zuoshun
    Goncalves, Joana
    Nograles, Kristine
    Nikkels, Arjen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB245 - AB245
  • [8] Efficacy of guselkumab in patients with moderate-to-severe plaque psoriasis with involvement of the scalp, nails, hands, and feet: Results from the phase 3 VOYAGE 2 study
    Reich, Kristian
    Armstrong, April W.
    Foley, Peter
    Song, Michael
    Wasfi, Yasmine
    Randazzo, Bruce
    Shen, Yaung-Kaung
    Gordon, Kenneth B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB120 - AB120
  • [9] Sustained improvement in general health-related quality life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 3-year data from clinical trial VOYAGE 2
    Reich, K.
    Gordon, K. B.
    Foley, P.
    Lomaga, M.
    Han, C.
    Song, M.
    Shen, Y. -K.
    Radtke, M. A.
    Wu, J. J.
    Armstrong, A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB280 - AB280
  • [10] Efficacy of guselkumab within specific body regions in patients with moderate-to-severe plaque psoriasis: Results from the phase 3 VOYAGE 1 study
    Blauvelt, Andrew
    Papp, Kim
    Griffiths, Christopher E. M.
    Randazzo, Bruce
    Wasfi, Yasmine
    Shen, Yaung-Kaung
    Kimball, Alexa B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB120 - AB120
12345